An APRIL to remember: novel TNF ligands as therapeutic targets
SR Dillon, JA Gross, SM Ansell, AJ Novak - Nature reviews Drug …, 2006 - nature.com
SR Dillon, JA Gross, SM Ansell, AJ Novak
Nature reviews Drug discovery, 2006•nature.comSince their discovery in 1998, the two TNF family members APRIL and BLyS/BAFF have
received increasing attention. In addition to regulating normal B-cell development and
immune responses, these molecules might be crucial in a diverse set of diseases, including
autoimmunity and cancer. Although more has been published about the general biology of
BLyS/BAFF than that of APRIL, many recent articles have described novel APRIL biology.
Here we focus on APRIL, exploring its normal and pathological functions, and comparing the …
received increasing attention. In addition to regulating normal B-cell development and
immune responses, these molecules might be crucial in a diverse set of diseases, including
autoimmunity and cancer. Although more has been published about the general biology of
BLyS/BAFF than that of APRIL, many recent articles have described novel APRIL biology.
Here we focus on APRIL, exploring its normal and pathological functions, and comparing the …
Abstract
Since their discovery in 1998, the two TNF family members APRIL and BLyS/BAFF have received increasing attention. In addition to regulating normal B-cell development and immune responses, these molecules might be crucial in a diverse set of diseases, including autoimmunity and cancer. Although more has been published about the general biology of BLyS/BAFF than that of APRIL, many recent articles have described novel APRIL biology. Here we focus on APRIL, exploring its normal and pathological functions, and comparing the therapeutic molecules currently under development that target BLyS/BAFF alone, or APRIL and BLyS/BAFF together.
nature.com